Sien‐Sing Yang

2.0k total citations
61 papers, 1.4k citations indexed

About

Sien‐Sing Yang is a scholar working on Hepatology, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sien‐Sing Yang has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hepatology, 32 papers in Epidemiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sien‐Sing Yang's work include Liver Disease Diagnosis and Treatment (28 papers), Liver Disease and Transplantation (17 papers) and Hepatitis C virus research (15 papers). Sien‐Sing Yang is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Liver Disease and Transplantation (17 papers) and Hepatitis C virus research (15 papers). Sien‐Sing Yang collaborates with scholars based in Taiwan, United States and China. Sien‐Sing Yang's co-authors include Ming‐Ling Chang, Nai‐Shin Chu, Yun‐Fan Liaw, Ding‐Shinn Chen, Ching‐Shan Huang, Zinger Yang, Ming‐Lung Yu, Chia‐Ming Chu, Tong‐Jong Chen and Jia‐Horng Kao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Sien‐Sing Yang

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sien‐Sing Yang Taiwan 20 746 740 227 167 117 61 1.4k
Peter Ferenci Austria 17 451 0.6× 417 0.6× 170 0.7× 45 0.3× 138 1.2× 19 1.6k
Takeshi Nishimura Japan 19 575 0.8× 207 0.3× 351 1.5× 79 0.5× 258 2.2× 110 1.3k
José Antonio Durán Spain 13 397 0.5× 306 0.4× 103 0.5× 213 1.3× 53 0.5× 31 1.9k
Z. Gordon Jiang United States 23 705 0.9× 420 0.6× 336 1.5× 22 0.1× 335 2.9× 88 1.6k
Michael Voelker Germany 14 834 1.1× 661 0.9× 139 0.6× 14 0.1× 122 1.0× 27 1.3k
J.W.O. van den Berg Netherlands 22 269 0.4× 207 0.3× 328 1.4× 102 0.6× 196 1.7× 52 1.3k
Behnam Saberi United States 18 592 0.8× 648 0.9× 439 1.9× 46 0.3× 277 2.4× 76 1.8k
R. B. Sewell Australia 16 220 0.3× 170 0.2× 236 1.0× 89 0.5× 255 2.2× 53 1.0k
Tatsushi Omatsu Japan 19 799 1.1× 214 0.3× 373 1.6× 74 0.4× 320 2.7× 36 1.7k
Yona Avni Israel 21 302 0.4× 306 0.4× 190 0.8× 24 0.1× 443 3.8× 56 1.3k

Countries citing papers authored by Sien‐Sing Yang

Since Specialization
Citations

This map shows the geographic impact of Sien‐Sing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sien‐Sing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sien‐Sing Yang more than expected).

Fields of papers citing papers by Sien‐Sing Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sien‐Sing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sien‐Sing Yang. The network helps show where Sien‐Sing Yang may publish in the future.

Co-authorship network of co-authors of Sien‐Sing Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Sien‐Sing Yang. A scholar is included among the top collaborators of Sien‐Sing Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sien‐Sing Yang. Sien‐Sing Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Wei‐Chih, et al.. (2022). The effect of a pay-for-performance program on health-related quality of life for patients with hepatitis in Taiwan. Health and Quality of Life Outcomes. 20(1). 130–130. 2 indexed citations
2.
Chen, Hsin‐Yi, et al.. (2020). Triple-negative breast cancer with calcified metastases of hepatic, portal vein and inferior vena cava: Report of a case and review of the literature. Journal of the Formosan Medical Association. 119(9). 1431–1434. 1 indexed citations
3.
4.
Chou, Yi‐Hong, Ja‐Der Liang, Shen-Yung Wang, et al.. (2019). Safety of perfluorobutane (Sonazoid) in characterizing focal liver lesions. SHILAP Revista de lepidopterología. 27(2). 81–81. 16 indexed citations
5.
Qi, Xingshun, Xiaozhong Guo, Eric M. Yoshida, et al.. (2018). Transient portal vein thrombosis in liver cirrhosis. BMC Medicine. 16(1). 83–83. 45 indexed citations
6.
Yu, Ming‐Lung, Chuan–Mo Lee, Chi‐Ling Chen, et al.. (2013). Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology. 57(6). 2135–2142. 53 indexed citations
7.
Huang, Chi‐Chang, et al.. (2012). Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis. The Journal of Nutritional Biochemistry. 24(3). 516–530. 50 indexed citations
8.
Yang, Sien‐Sing, et al.. (2010). Bioactive γ-Lactones from the Fermented Broth ofNeosartoryasp.. Planta Medica. 76(15). 1701–1705. 4 indexed citations
9.
Yang, Sien‐Sing, et al.. (2009). New Constituents with iNOS Inhibitory Activity from Mycelium ofAntrodia camphorata. Planta Medica. 75(5). 512–516. 54 indexed citations
10.
Liu, Chun‐Jen, Wan‐Long Chuang, Chuan–Mo Lee, et al.. (2008). Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses. Gastroenterology. 136(2). 496–504.e3. 144 indexed citations
11.
Liu, Chun‐Jen, Ming‐Yang Lai, You‐Chen Chao, et al.. (2006). Interferon α‐2b with and without ribavirin in the treatment of hepatitis B e antigen–positive chronic hepatitis B. Hepatology. 43(4). 742–749. 36 indexed citations
12.
Yang, Sien‐Sing. (2005). Effects of ethanol on antioxidant capacity in isolated rat hepatocytes. World Journal of Gastroenterology. 11(46). 7272–7272. 21 indexed citations
13.
Yang, Sien‐Sing, et al.. (2004). Role of zinc in subclinical hepatic encephalopathy: Comparison with somatosensory‐evoked potentials. Journal of Gastroenterology and Hepatology. 19(4). 375–379. 14 indexed citations
14.
15.
Yang, Sien‐Sing. (2002). Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. World Journal of Gastroenterology. 8(5). 868–868. 11 indexed citations
16.
Chiu, King‐Wah, Chi‐Sin Changchien, Yun‐Fan Liaw, & Sien‐Sing Yang. (2001). Albumin gradient and portal vein velocity in severe viral hepatitis patients complicated with ascites.. PubMed. 47(36). 1700–2. 2 indexed citations
17.
Yang, Sien‐Sing, et al.. (1998). Somatosensory evoked potentials in subclinical portosystemic encephalopathy: A comparison with psychometric tests. Hepatology. 27(2). 357–361. 41 indexed citations
18.
Yang, Sien‐Sing, et al.. (1995). Portal blood flow in acute hepatitis with and without ascites: A non‐invasive measurement using an ultrasonic Doppler. Journal of Gastroenterology and Hepatology. 10(1). 36–41. 14 indexed citations
19.
Yang, Sien‐Sing, et al.. (1988). Portal-systemic encephalopathy: alterations in somatosensory and brainstem auditory evoked potentials. Journal of the Neurological Sciences. 84(1). 41–50. 25 indexed citations
20.
Yang, Sien‐Sing, Robin D. Hughes, & Roger Williams. (1988). Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose. Hepatology. 8(1). 93–97. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Ferenci Breakdown of academic impact, for papers by Takeshi Nishimura Breakdown of academic impact, for papers by José Antonio Durán Breakdown of academic impact, for papers by Z. Gordon Jiang Breakdown of academic impact, for papers by Michael Voelker Breakdown of academic impact, for papers by J.W.O. van den Berg Breakdown of academic impact, for papers by Behnam Saberi Breakdown of academic impact, for papers by R. B. Sewell Breakdown of academic impact, for papers by Tatsushi Omatsu Breakdown of academic impact, for papers by Yona Avni
Rankless by CCL
2026